Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KLAC vs MRNA✓SelectedUSD · MRNAKLAC vs MRNA performance historyLatest closeAs of-10.33%11/20
Stock and ETF performance explorer

KLAC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+226.2%
MRNA return
-27.3%
Excess return
+253.4%
Maximum drawdown
-57.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-10.3%-2.2%-8.2%-10.2%
7D-16.6%-12.7%-3.9%-15.7%
30D-22.3%-20.7%-1.6%-20.9%
3M-31.6%+46.3%-77.9%-33.6%
6M-30.5%+305.2%-335.7%-44.6%
YTD+5.0%+561.2%-556.3%-25.8%
1Y+15.7%+772.1%-756.4%-23.3%
3Y+132.7%+147.0%-14.3%+87.1%
All+226.2%-27.3%+253.4%+196.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling